VIDEX CHEWABLE DISPERSIBLE TAB 150MG 150 MG
DIDANOSINE : 150 MG · DIN 01940554 · BRISTOL-MYERS SQUIBB CANADA
Health Canada status: CANCELLED POST MARKET
What is VIDEX CHEWABLE DISPERSIBLE TAB 150MG?
VIDEX CHEWABLE DISPERSIBLE TAB 150MG 150 MG contains DIDANOSINE : 150 MG. It is listed in the Health Canada Drug Product Database under DIN 01940554, held by BRISTOL-MYERS SQUIBB CANADA, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 01-May-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is VIDEX CHEWABLE DISPERSIBLE TAB 150MG called?
The same molecule, DIDANOSINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Videx | Latin | Morocco, South Africa |
| Aspen Didanosine | Latin | South Africa |
| DINEX | Latin | Morocco |
| Videx paed | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 01940554 |
|---|---|
| Brand name | VIDEX CHEWABLE DISPERSIBLE TAB 150MG |
| Generic / active ingredient | DIDANOSINE : 150 MG |
| Manufacturer | BRISTOL-MYERS SQUIBB CANADA |
| Strength | 150 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AF02 DIDANOSINE |
| AHFS class | 08:18.08.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-May-2007 |
| Original market date | 1991-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 01940554 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1940554 |
| Brand name | VIDEX CHEWABLE DISPERSIBLE TAB 150MG |
| Active ingredient / INN | DIDANOSINE : 150 MG |
| ATC code | J05AF02 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J05 |
| AHFS class | 08:18.08.20 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | BRISTOL-MYERS SQUIBB CANADA |
Which pack is which?
| Strength on the label | 150 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code J05AF02 DIDANOSINE. 0 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| VIDEX CHEWABLE DISPERSIBLE TAB 100MG | 100 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 01940546 |
| VIDEX CHEWABLE DISPERSIBLE TAB 25MG | 25 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 01940511 |
| VIDEX CHEWABLE DISPERSIBLE TAB 50MG | 50 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 01940538 |
| VIDEX EC | 125 MG | CAPSULE (ENTERIC-COATED) | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02244596 |
| VIDEX EC | 200 MG | CAPSULE (ENTERIC-COATED) | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02244597 |
| VIDEX EC | 250 MG | CAPSULE (ENTERIC-COATED) | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02244598 |
| VIDEX EC | 400 MG | CAPSULE (ENTERIC-COATED) | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02244599 |
| VIDEX PEDIATRIC POWDER SOL 4G/BOTT | 4 G | POWDER FOR SOLUTION | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 01940635 |
How much does DIDANOSINE cost around the world?
DIDANOSINE is listed on 2 national price registers Nexara tracks, across 20 pack listings published on 2 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| South Africa | single exit price | 12 | 18 | 01 Sep 2026 |
| Morocco | PPV (public price) | 2 | 2 | 05 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.